BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34943931)

  • 1. The Novel Phosphatase Domain Mutations Q171R and Y65S Switch PTEN from Tumor Suppressor to Oncogene.
    Garrido JAMG; Alcantara KMM; Danac JMC; Serrano FEC; Cutiongco-de la Paz EM; Garcia RL
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of phosphoinositide metabolism, Akt phosphorylation, and glucose transport by PTEN (phosphatase and tensin homolog deleted on chromosome 10) in 3T3-L1 adipocytes.
    Ono H; Katagiri H; Funaki M; Anai M; Inukai K; Fukushima Y; Sakoda H; Ogihara T; Onishi Y; Fujishiro M; Kikuchi M; Oka Y; Asano T
    Mol Endocrinol; 2001 Aug; 15(8):1411-22. PubMed ID: 11463863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship between PTEN mutations and protein kinase B phosphorylation caused by insulin or recombinant human epidermal growth factor stimulation].
    Zhong H; Hu X; Lin J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1065-8. PubMed ID: 27412938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-Redundant and Overlapping Oncogenic Readouts of Non-Canonical and Novel Colorectal Cancer KRAS and NRAS Mutants.
    Alcantara KMM; Malapit JRP; Yu RTD; Garrido JAMG; Rigor JPT; Angeles AKJ; Cutiongco-de la Paz EM; Garcia RL
    Cells; 2019 Dec; 8(12):. PubMed ID: 31816869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN, more than the AKT pathway.
    Blanco-Aparicio C; Renner O; Leal JF; Carnero A
    Carcinogenesis; 2007 Jul; 28(7):1379-86. PubMed ID: 17341655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-21 (Mir-21) Promotes Cell Growth and Invasion by Repressing Tumor Suppressor PTEN in Colorectal Cancer.
    Wu Y; Song Y; Xiong Y; Wang X; Xu K; Han B; Bai Y; Li L; Zhang Y; Zhou L
    Cell Physiol Biochem; 2017; 43(3):945-958. PubMed ID: 28957811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTEN lipid phosphatase activity and proper subcellular localization are necessary and sufficient for down-regulating AKT phosphorylation in the nucleus in Cowden syndrome.
    He X; Saji M; Radhakrishnan D; Romigh T; Ngeow J; Yu Q; Wang Y; Ringel MD; Eng C
    J Clin Endocrinol Metab; 2012 Nov; 97(11):E2179-87. PubMed ID: 22962422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN.
    Ramírez-Moya J; Wert-Lamas L; Santisteban P
    Oncogene; 2018 Jun; 37(25):3369-3383. PubMed ID: 29353884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of the PTEN Tumor Suppressor and Its Connection to the PI3K and AKT Oncogenes.
    Parsons R
    Cold Spring Harb Perspect Med; 2020 Aug; 10(8):. PubMed ID: 31932465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis.
    Xu W; Yang Z; Xie C; Zhu Y; Shu X; Zhang Z; Li N; Chai N; Zhang S; Wu K; Nie Y; Lu N
    J Exp Clin Cancer Res; 2018 Aug; 37(1):198. PubMed ID: 30134988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel RON splice variant lacking exon 2 activates the PI3K/AKT pathway via PTEN phosphorylation in colorectal carcinoma cells.
    Ling Y; Kuang Y; Chen LL; Lao WF; Zhu YR; Wang LQ; Wang D
    Oncotarget; 2017 Jun; 8(24):39101-39116. PubMed ID: 28388571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kaempferol promotes apoptosis in human bladder cancer cells by inducing the tumor suppressor, PTEN.
    Xie F; Su M; Qiu W; Zhang M; Guo Z; Su B; Liu J; Li X; Zhou L
    Int J Mol Sci; 2013 Oct; 14(11):21215-26. PubMed ID: 24284390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells.
    Bouali S; Chrétien AS; Ramacci C; Rouyer M; Becuwe P; Merlin JL
    Oncol Rep; 2009 Mar; 21(3):731-5. PubMed ID: 19212633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting mutants of PTEN reveal distinct subsets of tumour suppressor functions.
    Leslie NR; Bennett D; Gray A; Pass I; Hoang-Xuan K; Downes CP
    Biochem J; 2001 Jul; 357(Pt 2):427-35. PubMed ID: 11439092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
    Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
    Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear-cytoplasmic partitioning of phosphatase and tensin homologue deleted on chromosome 10 (PTEN) differentially regulates the cell cycle and apoptosis.
    Chung JH; Eng C
    Cancer Res; 2005 Sep; 65(18):8096-100. PubMed ID: 16166282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different splicing defects lead to differential effects downstream of the lipid and protein phosphatase activities of PTEN.
    Agrawal S; Pilarski R; Eng C
    Hum Mol Genet; 2005 Aug; 14(16):2459-68. PubMed ID: 16014636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation and modulation of PTEN activity.
    Naderali E; Khaki AA; Rad JS; Ali-Hemmati A; Rahmati M; Charoudeh HN
    Mol Biol Rep; 2018 Dec; 45(6):2869-2881. PubMed ID: 30145641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphatome profiling reveals PTPN2, PTPRJ and PTEN as potent negative regulators of PKB/Akt activation in Ras-mutated cancer cells.
    Omerovic J; Clague MJ; Prior IA
    Biochem J; 2010 Jan; 426(1):65-72. PubMed ID: 19922411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-205 inhibits cell apoptosis by targeting phosphatase and tensin homolog deleted on chromosome ten in endometrial cancer Ishikawa cells.
    Zhang G; Hou X; Li Y; Zhao M
    BMC Cancer; 2014 Jun; 14():440. PubMed ID: 24929707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.